Core Viewpoint - SRx Health Solutions, Inc. has canceled an additional 350,000 shares, bringing the total canceled shares to over 19 million as part of a Settlement Agreement with certain founders and former officers of its Canadian subsidiary [1][2] Group 1: Share Cancellation and Settlement - The cancellation of shares was executed under a Settlement, Share Forfeiture and Mutual Release Agreement with specific parties [1] - Approximately 19 million exchangeable shares were forfeited by certain founders and former officers of SRx Canada, originally issued during the acquisition of SRx Canada [2] Group 2: Legal Actions - The company plans to explore all available legal remedies against former officers of SRx Canada who are not part of the Settlement Agreement to recover lost value for its stockholders [3] Group 3: Company Overview - SRx Health Solutions, Inc. is a leading integrated healthcare services provider in Canada, operating within the specialty healthcare industry across all ten provinces [4] - The company focuses on creating strategies and solutions that enhance patient care and wellness in Canada [4]

Core Points - SRx Health Solutions, Inc. received a notice from NYSE Regulation indicating non-compliance with listing standards due to the failure to timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 [1] - The company is currently working with auditors to complete the delinquent report and anticipates filing it before the cure period deadline [3] - The notice does not immediately affect the trading of the company's common stock, and the company is confident in regaining compliance with the exchange's listing standards [4] Company Overview - SRx Health Solutions, Inc. is a leading integrated healthcare services provider in Canada, operating within the specialty healthcare industry across all ten provinces [5] - The company focuses on creating patient-centric strategies and solutions to improve wellness and exceed client expectations [5]

TAMPA, Fla., Aug. 18, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) ("SRx Health" or the "Company"), a leading global health and wellness company, today announced that is has signed a non-binding Letter of Intent to purchase 100% of the assets of Royal Uranium Inc., a leading uranium royalty business with a portfolio spanning Canada, Colombia, Argentina and Namibia. The acquisition is subject to customary closing conditions, including the negotiation and execution of definitive t ...

SRx Health Solutions Inc. is an integrated Canadian healthcare services provider that operates within the specialty healthcare industry. The SRx network extends across all ten Canadian provinces, making it one of the most accessible providers of comprehensive, integrated, and customized specialty healthcare services in the country.SRx combines years of industry knowledge, technology, and patient-centric focus to create strategies and solutions that consistently exceed client expectations and drive critical ...

Core Viewpoint - SRx Health Solutions, Inc. announced that its subsidiary, SRx Health Solutions (Canada), Inc., has obtained an Initial Order under the Companies' Creditors Arrangement Act in Canada, allowing for restructuring and financing to stabilize operations and explore potential sales of its business or assets [1][2]. Group 1: Initial Order and CCAA Proceedings - The Ontario Superior Court of Justice granted an Initial Order for SRx Canada under the CCAA, enabling the company to restructure its operations [1][2]. - The Initial Order includes a stay of proceedings in favor of SRx Canada and the appointment of Grant Thornton Limited as the Monitor [6]. Group 2: Financing and Operations - SRx Canada has secured debtor-in-possession (DIP) financing of up to $1,750,000, which will be used for working capital needs and to support ongoing operations during the restructuring process [2][6]. - The DIP financing is expected to provide the necessary time and stability for SRx Canada to complete a Sale Process, which may involve selling all or substantially all of its business or assets [2]. Group 3: Company Overview - SRx Health Solutions, Inc. is a leading integrated healthcare services provider in Canada, operating across all ten provinces and focusing on specialty healthcare services [4]. - The company combines industry knowledge, technology, and a patient-centric approach to enhance patient care and wellness initiatives in Canada [4].

Core Viewpoint - SRx Health Solutions, Inc. has announced that its Canadian subsidiary, SRx Health Solutions (Canada), Inc., is seeking creditor protection under the Companies' Creditors Arrangement Act (CCAA) in Canada, while its U.S. operations, including the Halo subsidiary, will remain unaffected and no U.S. bankruptcy filing is expected [1][4]. Group 1: CCAA Proceedings - The decision to seek creditor protection was made in the best interest of stakeholders after evaluating SRx Canada's financial situation and consulting with legal and financial advisors [2]. - In the CCAA Proceedings, SRx Canada aims to obtain a stay of proceedings and approval for debtor-in-possession financing (DIP Financing) to allow time for potential restructuring transactions and maximize asset value for stakeholders [3]. - The company plans to continue critical business operations during the CCAA Proceedings [3]. Group 2: Impact on U.S. Operations - The company anticipates that neither it nor any of its U.S. assets, including the Halo subsidiary, will be affected by the CCAA Proceedings, and no bankruptcy proceedings will be initiated in the United States [4]. Group 3: Company Overview - SRx Health Solutions, Inc. is an integrated Canadian healthcare services provider operating within the specialty healthcare industry, with a network that spans all ten Canadian provinces [5]. - The company combines industry knowledge, technology, and a patient-centric focus to create strategies aimed at improving the wellness of Canadians [5].

Core Viewpoint - SRx Health Solutions, Inc. has successfully closed a $7.3 million convertible note financing and secured a $50 million equity line of credit, significantly strengthening its balance sheet and providing additional working capital for growth initiatives [1][2] Financing Details - The $7.3 million financing was led by insiders and existing investors, marking a pivotal milestone in the company's transformation into a leading North American healthcare provider [1][2] - The $50 million equity line of credit (ELOC) provides the company with the option to pursue accretive M&A opportunities in the U.S. while scaling its specialty pharma platform in Canada [2] Strategic Focus - The combined proceeds from the financing will support SRx Health's acquisition pipeline in the U.S., enhance its Canadian specialty pharma footprint, and invest in next-generation capabilities to improve patient access and operational efficiency [2][3] - SRx Health operates as an integrated healthcare services provider within the specialty healthcare industry, with a network that spans all ten Canadian provinces [3]

Core Insights - SRx Health Solutions, Inc. has announced significant changes in its management team and Board of Directors, with Lionel Conacher appointed as Chairman, Adesh Vora as CEO, Kent Cunningham as President, and Nina Martinez as CFO [1][2] Management Changes - Lionel Conacher has been appointed as Chairman of the Board [1] - Adesh Vora, previously Executive Chairman, will now serve as Chief Executive Officer while remaining on the Board [1] - Kent Cunningham, the current CEO, will transition to the role of President [1] - Nina Martinez has been appointed as Chief Financial Officer [1] Strategic Focus - The company aims to enhance corporate governance and strengthen its team structure to support long-term strategic growth [2] - Core focus areas include managing chronic and rare diseases, infusion services, clinical trials, and patient support programs [2] - The company emphasizes its commitment to partnering with patients, pharmaceutical manufacturers, and prescriber relations [2] Company Overview - SRx Health Solutions, Inc. is a leading integrated healthcare services provider in Canada, operating across all ten provinces [3] - The company specializes in the specialty healthcare industry, offering comprehensive, integrated, and customized services [3] - SRx combines industry knowledge, technology, and a patient-centric approach to improve wellness and exceed client expectations [3]

Core Viewpoint - SRx Health Solutions, Inc. is diversifying its treasury strategy by purchasing Ethereum (ETH) and has sold $1.5 million of Solana Tokens (SOL) to enhance long-term value for shareholders [1][2]. Company Overview - SRx Health Solutions, Inc. is a leading integrated healthcare services provider in Canada, operating across all ten provinces and focusing on specialty healthcare [3]. - The company combines industry knowledge, technology, and a patient-centric approach to deliver customized healthcare solutions [3].

Core Insights - SRx Health Solutions Inc. reported a significant improvement in its financial performance for Q1 2025, with EPS improving by 90% year-over-year to $(0.37) and adjusted EBITDA loss improving by 54% to $(0.6) million [1][9] - The company generated net sales of $7.2 million, a decrease of 9% year-over-year, primarily due to the closure of Halo's direct-to-consumer channel [4][9] - The merger with SRx Health Solutions was completed on April 24, 2025, leading to a name change from Better Choice Company Inc. to SRx Health Solutions Inc. [2] Financial Performance - Adjusted EBITDA margin improved by 865 basis points year-over-year to (9)% [1][9] - Net loss improved by 66% year-over-year to $(1.0) million [9] - Gross margin remained consistent at 33% [9] Operational Highlights - The company executed a digital-first strategy and shifted marketing investments to enhance brand awareness [2] - Inventory levels improved by approximately 50% over the last 15 months, with fill rates averaging 98% for the quarter [2] - The financial results reported only reflect US operations prior to the merger and do not include Canadian operations [2] Liquidity and Capital Resources - As of March 31, 2025, cash and cash equivalents totaled $1.1 million [5]